Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Epilepsia|July 3, 2020
Thrombocytopenia in pediatric patients on concurrent cannabidiol and valproic acidNancy A McNamara, Louis T Dang, Julie Sturza, et al.International Journal of Radiation Oncology, Biology, Physics|April 10, 2009
A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931)Jeffrey Allen, Bernadine Donahue, Minesh Mehta, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 5, 2024
Long-Term Tumor Stability After First-Line Treatment With Larotrectinib in an Infant With NTRK2 Fusion-Positive High-Grade GliomaJillian Simoneau, Patricia Robertson, Karin Muraszko, et al.JCO Precision Oncology|December 1, 2025
Pediatric Oncology Patients With Germline Pathogenic Variants in Adult-Onset Cancer Predisposition GenesMichelle F Jacobs, Sarah Austin, Andrea M Murad, et al.Oncotarget|September 2, 2016
Characterizing and targeting PDGFRA alterations in pediatric high-grade gliomaCarl Koschmann, Daniel Zamler, Alan MacKay, et al.Neuro-Oncology|November 1, 2021
EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adultsDidier Frappaz, Girish Dhall, Matthew J Murray, et al.JCO Precision Oncology|August 25, 2020
Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain TumorsCarl Koschmann, Yi-Mi Wu, Chandan Kumar-Sinha, et al.Acta Neuropathologica Communications|July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG RegistryHunter C Gits, Maia Anderson, Stefanie Stallard, et al.Neuro-Oncology|February 9, 2022
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline gliomaEvan Cantor, Kyle Wierzbicki, Rohinton S Tarapore, et al.Pageof 2